• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CareDx, Inc. - Common Stock (NQ:CDNA)

    68.00 +0.84 (+1.26%)
    Delayed Quote Updated: 10:54 AM EDT, Oct 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CareDx, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case ↗
    Via Chartmill
    CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum ↗
    Via Chartmill
    CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup ↗
    Via Chartmill
    CareDx (NASDAQ:CDNA) Shows Strong Growth Fundamentals by Passing All Eight Rules of Navellier's Screen ↗
    Via Chartmill
    CareDx (NASDAQ:CDNA) Combines Strong Growth With a Bullish Technical Setup ↗
    Via Chartmill
    CareDx (NASDAQ:CDNA) Passes Minervini Trend Template and High Growth Momentum Screen ↗
    Via Chartmill
    News headline image
    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx (NASDAQ:CDNA) Posts Accelerating Growth and Strengthening Fundamentals ↗
    Via Chartmill
    News headline image
    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests ↗
    Via Chartmill
    CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup ↗
    Via Chartmill
    News headline image
    Why CareDx Stock Jumped Today ↗
    The diagnostics leader is accelerating the trend toward precision medicine. 
    Via The Motley Fool
    News headline image
    CareDx Q2 Earnings Call Highlights ↗
    CareDx (NASDAQ:CDNA) reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics company expanded testing services, completed the sale of its lab products business and began... 
    Via MarketBeat
    Topics Earnings
    News headline image
    CareDx Announces Second Quarter 2026 Financial Results
    From CareDx, Inc.
    Via Business Wire
    What's going on in today's session ↗
    Via Chartmill
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx's CEO Sells 17K Shares ↗
    CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans ↗
    CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted... 
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies ↗
    CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing... 
    Via MarketBeat
    News headline image
    CareDx to Participate in Upcoming Investor Conferences
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Dismissal of 2021 Qui Tam Suit
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx (CDNA) Q1 2026 Earnings Call Transcript ↗
    CareDx (CDNA) Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.